Innate immunity and inflammation: a transcriptional paradigm.

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• The innate immune response and inflammation are interconnected processes.
• Excessive cytokine production, driven by bacterial products like lipopolysaccharides (LPS), causes life-threatening systemic inflammatory response (IR).
• Nuclear factor-kappa B (NF-kappaB) and other stress-responsive transcription factors (SRTFs) mediate inflammatory gene expression.

Purpose of the Study:

• To develop and evaluate a novel method to block NF-kappaB nuclear import.
• To investigate the therapeutic potential of inhibiting NF-kappaB and SRTFs in a lethal LPS-induced inflammatory model.

Main Methods:

• Development of cell-permeable peptides to antagonize NF-kappaB and SRTF nuclear import.
• Administration of these peptides to monocytes, macrophages, T lymphocytes, and endothelial cells.
• Testing the peptide's efficacy in mice challenged with a lethal dose of LPS.

Main Results:

• The peptide successfully blocked NF-kappaB and SRTF nuclear import in relevant cell types.
• Systemic production of pro-inflammatory cytokines, including TNF-alpha and interferon-gamma, was significantly suppressed in treated mice.
• Survival rates in mice challenged with lethal LPS increased by at least 90%.

Conclusions:

• Systemic inflammatory responses are critically dependent on NF-kappaB and SRTF-mediated transcriptional activation of cytokine genes.
• Blocking NF-kappaB nuclear import via cell-permeable peptides offers a promising therapeutic strategy for life-threatening inflammatory conditions.
• This approach has significant potential for treating sepsis and other LPS-induced inflammatory diseases.